{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:33:42Z","timestamp":1774524822212,"version":"3.50.1"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T00:00:00Z","timestamp":1720915200000},"content-version":"vor","delay-in-days":195,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Pandemic preparedness is explored for the antibiotic resistance crisis and the threat of a next viral pandemic. Bacterial pathogens escaping from control by antibiotics are well defined, and resistance develops over decades while a next viral pandemic occurs suddenly with a novel virus. The death toll for resistant bacterial infections is reviewed, and the scientific and economic hurdles to the development of new antibiotics are discussed. Regulatory adaptations and financial push and pull programs to restimulate new antibiotic development are explored. The COVID-19 pandemic caused not only millions of deaths, but also economic losses in excess of 10 trillion US dollars. Coronaviruses and influenza viruses remain usual suspects for new viral pandemics, followed by paramyxoviruses. Viral infections at the animal\u2013human interface in wet markets and in disturbed environments need active virus surveillance programs. Learning lessons from the COVID-19 for non-pharmaceutical interventions is difficult to draw since measures were frequently applied in combination against different variant viruses and against changing population immunity levels. The Randomised Evaluation of COVID-19 Therapy (RECOVERY) clinical trials demonstrated that even under emergency situations clinical trials can rapidly provide solid treatment data. Various novel vaccine approaches were the most efficient control measures for the COVID-19 pandemic. Pandemic preparedness also requires a fact-based discussion both in the public and in parliaments to settle the conflict between individual freedom and necessary restrictions during a pandemic. Mature and educated citizens are needed not only for coping with pandemics but also for creating stress-resistant democratic societies. Learned scientific societies should contribute to this discussion.<\/jats:p>","DOI":"10.1093\/sumbio\/qvae018","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T02:37:31Z","timestamp":1720924651000},"source":"Crossref","is-referenced-by-count":2,"title":["Pandemic preparedness\u2014political perspectives"],"prefix":"10.1093","volume":"1","author":[{"given":"Harald","family":"Br\u00fcssow","sequence":"first","affiliation":[{"name":"Department of Biosystems, Laboratory of Gene Technology, KU Leuven , Kastelpark Arenberg 21, Leuven 3001 ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,7,13]]},"reference":[{"key":"2024121909173284000_bib1","doi-asserted-by":"crossref","first-page":"eabi9069","DOI":"10.1126\/science.abi9069","article-title":"Impact of community masking on COVID-19: a cluster-randomized trial in Bangladesh","volume":"375","author":"Abaluck","year":"2022","journal-title":"Science"},{"key":"2024121909173284000_bib2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41579-019-0293-3","article-title":"Antibiotic development\u2014economic, regulatory and societal challenges","volume":"18","author":"\u00c5rdal","year":"2020","journal-title":"Nat Rev Micro"},{"key":"2024121909173284000_bib3","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/clpt.2014.145","article-title":"Accelerated access to innovative medicines for patients in need","volume":"96","author":"Baird","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"2024121909173284000_bib4","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1021\/acsinfecdis.0c00101","article-title":"The Global Antibiotic Research and Development Partnership (GARDP) not-for-profit model of antibiotic development","volume":"6","author":"Balasegaram","year":"2020","journal-title":"ACS Infect Dis"},{"key":"2024121909173284000_bib5","first-page":"741","article-title":"SARS-Cov-2\/COVID-19: clinical characteristics, prevention and treatment","volume-title":"Field\u2019s Virology Vol. 3 RNA Viruses","author":"Beigel","year":"2023"},{"key":"2024121909173284000_bib6","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S1473-3099(20)30314-5","article-title":"Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series","volume":"20","author":"B\u00f6hmer","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2024121909173284000_bib7","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.12688\/f1000research.19043.1","article-title":"Probiotics and prebiotics in clinical tests: an update","volume":"8","author":"Br\u00fcssow","year":"2019","journal-title":"F1000Res"},{"key":"2024121909173284000_bib8","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1111\/1462-2920.15769","article-title":"Clinical trials with antiviral drugs against COVID-19: some progress and many shattered hopes","volume":"23","author":"Br\u00fcssow","year":"2021","journal-title":"Environ Microbiol"},{"key":"2024121909173284000_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/1751-7915.13974","article-title":"mRNA vaccines against COVID-19: a showcase for the importance of microbial biotechnology","volume":"15","author":"Br\u00fcssow","year":"2022","journal-title":"Microb Biotechnol"},{"key":"2024121909173284000_bib10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/1751-7915.14053","article-title":"The beginning and ending of a respiratory viral pandemic-lessons from the Spanish flu","volume":"15","author":"Br\u00fcssow","year":"2022","journal-title":"Microb Biotechnol"},{"key":"2024121909173284000_bib11","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/1751-7915.14269","article-title":"Viral infections at the animal\u2013human interface: learning lessons from the SARS-CoV-2 pandemic","volume":"16","author":"Br\u00fcssow","year":"2023","journal-title":"Microb Biotechnol"},{"key":"2024121909173284000_bib12","doi-asserted-by":"crossref","first-page":"e14431","DOI":"10.1111\/1751-7915.14431","article-title":"Pandemic preparedness: on the efficacy of non-pharmaceutical interventions in COVID-19 and about approaches to predict future pandemic viruses","volume":"17","author":"Br\u00fcssow","year":"2024","journal-title":"Microb Biotechnol"},{"key":"2024121909173284000_bib13","doi-asserted-by":"crossref","first-page":"e14389","DOI":"10.1111\/1751-7915.14389","article-title":"Avian influenza virus cross-infections as test case for pandemic preparedness: from epidemiological hazard models to sequence-based early viral warning systems","volume":"17","author":"Br\u00fcssow","year":"2024","journal-title":"Microb Biotechnol"},{"key":"2024121909173284000_bib14","doi-asserted-by":"crossref","first-page":"e14510","DOI":"10.1111\/1751-7915.14510","article-title":"The antibiotic resistance crisis and the development of new antibiotics","volume":"17","author":"Br\u00fcssow","year":"2024","journal-title":"Microb Biotechnol"},{"key":"2024121909173284000_bib15","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1111\/1751-7915.13889","article-title":"Clinical evidence that the pandemic from 1889 to 1891 commonly called the Russian flu might have been an earlier coronavirus pandemic","volume":"14","author":"Br\u00fcssow","year":"2021","journal-title":"Microb Biotechnol"},{"key":"2024121909173284000_bib16","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-022-04788-w","article-title":"Climate change increases cross-species viral transmission risk","volume":"607","author":"Carlson","year":"2022","journal-title":"Nature"},{"key":"2024121909173284000_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2024121909173284000_bib18","first-page":"519","article-title":"Finding the gems using genomic discovery: antibacterial drug discovery strategies\u2014the successes and the challenges","volume":"1","author":"Chan","year":"2004","journal-title":"Drug Discov Today: Ther Strategies"},{"key":"2024121909173284000_bib19","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1016\/j.cell.2023.08.029","article-title":"Host traits shape virome composition and virus transmission in wild small mammals","volume":"186","author":"Chen","year":"2023","journal-title":"Cell"},{"key":"2024121909173284000_bib20","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1126\/science.adq8854","article-title":"Global pandemic treaty stalls, again, over equity concerns","volume":"384","author":"Cohen","year":"2024","journal-title":"Science"},{"key":"2024121909173284000_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1126\/science.adp6024","article-title":"Worries about bird flu in U.S. cattle intensify","volume":"384","author":"Cohen","year":"2024","journal-title":"Science"},{"key":"2024121909173284000_bib22","doi-asserted-by":"crossref","first-page":"eabo7793","DOI":"10.1126\/scitranslmed.abo7793","article-title":"The past, present, and future of antibiotics","volume":"14","author":"Cook","year":"2022","journal-title":"Sci Transl Med"},{"key":"2024121909173284000_bib23","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/jama.2020.19759","article-title":"The COVID-19 pandemic and the $16 trillion virus","volume":"324","author":"Cutler","year":"2020","journal-title":"JAMA"},{"key":"2024121909173284000_bib24","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jama.2019.20288","article-title":"FDA approval and regulation of pharmaceuticals, 1983\u20132018","volume":"323","author":"Darrow","year":"2020","journal-title":"JAMA"},{"key":"2024121909173284000_bib25","doi-asserted-by":"crossref","first-page":"e1002184","DOI":"10.1371\/journal.pmed.1002184","article-title":"Will 10 million people die a year due to antimicrobial resistance by 2050?","volume":"13","author":"de\u00a0Kraker","year":"2016","journal-title":"PLoS Med"},{"key":"2024121909173284000_bib26","doi-asserted-by":"crossref","first-page":"e4444","DOI":"10.1093\/cid\/ciaa859","article-title":"An analysis of antibacterial drug development trends in the United States, 1980\u20132019","volume":"73","author":"Dheman","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024121909173284000_bib27","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/d41586-022-01341-7","article-title":"Tallying the health toll of COVID-19","volume":"605","author":"Else","year":"2022","journal-title":"Nature"},{"key":"2024121909173284000_bib28","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1021\/acsinfecdis.0c00069","article-title":"Fostering antibiotic development through impact funding","volume":"6","author":"Engel","year":"2020","journal-title":"ACS Infect Dis"},{"key":"2024121909173284000_bib30","first-page":"1204","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","journal-title":"Lancet North Am Ed"},{"key":"2024121909173284000_bib31","first-page":"2221","article-title":"Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"400","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2022","journal-title":"Lancet North Am Ed"},{"key":"2024121909173284000_bib33","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2022.02.014","article-title":"Virome characterization of game animals in China reveals a spectrum of emerging pathogens","volume":"185","author":"He","year":"2022","journal-title":"Cell"},{"key":"2024121909173284000_bib34","doi-asserted-by":"crossref","first-page":"e861","DOI":"10.1016\/S2214-109X(19)30071-3","article-title":"Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries","volume":"7","author":"Hsia","year":"2019","journal-title":"Lancet Glob Health"},{"key":"2024121909173284000_bib35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41586-022-05049-6","article-title":"Wastewater sequencing reveals early cryptic SARS-CoV-2 variant transmission","volume":"609","author":"Karthikeyan","year":"2022","journal-title":"Nature"},{"key":"2024121909173284000_bib36","volume-title":"A Dictionary of Epidemiology","author":"Last","year":"2001","edition":"4th edn"},{"key":"2024121909173284000_bib37","first-page":"559","article-title":"Henipaviruses: Hendra and Nipah viruses","volume-title":"Field\u2019s Virology Vol. 1 Emerging Viruses","author":"Lee","year":"2021"},{"key":"2024121909173284000_bib38","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1473-3099(20)30330-3","article-title":"Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial","volume":"21","author":"Leitner","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2024121909173284000_bib39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cell.2020.02.056","article-title":"The science of antibiotic discovery","volume":"181","author":"Lewis","year":"2020","journal-title":"Cell"},{"key":"2024121909173284000_bib40","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/d41586-024-00543-5","article-title":"What a treatment for \u201csuper gonorrhoea\u201d means for future drug development","volume":"626","author":"McKenna","year":"2024","journal-title":"Nature"},{"key":"2024121909173284000_bib41","doi-asserted-by":"crossref","first-page":"32293","DOI":"10.1073\/pnas.2015954117","article-title":"Face masks considerably reduce COVID-19 cases in Germany","volume":"117","author":"Mitze","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024121909173284000_bib42","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-024-07502-0","article-title":"A Gram-negative-selective antibiotic that spares the gut microbiome","volume":"630","author":"Mu\u00f1oz","year":"2024","journal-title":"Nature"},{"key":"2024121909173284000_bib43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s40258-023-00793-w","article-title":"Global pull incentives for better antibacterials: the UK leads the way","volume":"21","author":"Outterson","year":"2023","journal-title":"Appl Health Econ Health Policy"},{"key":"2024121909173284000_bib44","first-page":"410","article-title":"Coronaviridae: the viruses and their replication","volume-title":"Field\u2019s Virology Vol. 1 Emerging Viruses","author":"Perlman","year":"2021"},{"key":"2024121909173284000_bib45","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41564-024-01705-x","article-title":"Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study","volume":"9","author":"Pirnay","year":"2024","journal-title":"Nat Microbiol"},{"key":"2024121909173284000_bib46","doi-asserted-by":"crossref","first-page":"e4451","DOI":"10.1093\/cid\/ciaa852","article-title":"Antibacterial R&D at a crossroads: we've pushed as hard as we can \u2026 now we need to start pulling!","volume":"73","author":"Rex","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024121909173284000_bib47","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1016\/j.cell.2024.05.013","article-title":"Discovery of antimicrobial peptides in the global microbiome with machine learning","volume":"187","author":"Santos-J\u00fanior","year":"2024","journal-title":"Cell"},{"key":"2024121909173284000_bib48","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ebiom.2015.12.023","article-title":"Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh","volume":"4","author":"Sarker","year":"2016","journal-title":"EBioMedicine"},{"key":"2024121909173284000_bib49","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s40273-021-01065-y","article-title":"How much does it cost to research and develop a new drug? A systematic review and assessment","volume":"39","author":"Schlander","year":"2021","journal-title":"Pharmacoeconomics"},{"key":"2024121909173284000_bib50","first-page":"618","article-title":"HIV-1: pathogenesis, clinical manifestations, and treatment","volume-title":"Field\u2019s Virology Vol. 3 RNA Viruses","author":"Scully","year":"2023"},{"key":"2024121909173284000_bib51","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMoa1706988","article-title":"Single-dose zoliflodacin (ETX0914) for treatment of urogenital gonorrhea","volume":"379","author":"Taylor","year":"2018","journal-title":"N Engl J Med"},{"key":"2024121909173284000_bib52","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41586-023-06617-0","article-title":"Learning from prepandemic data to forecast viral escape","volume":"622","author":"Thadani","year":"2023","journal-title":"Nature"},{"key":"2024121909173284000_bib53","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1111\/1462-2920.15029","article-title":"The COVID-19 pandemic: some lessons learned about crisis preparedness and management, and the need for international benchmarking to reduce deficits","volume":"22","author":"Timmis","year":"2020","journal-title":"Environ Microbiol"},{"key":"2024121909173284000_bib54","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrd4572","article-title":"ESKAPEing the labyrinth of antibacterial discovery","volume":"14","author":"Tommasi","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"2024121909173284000_bib55","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1016\/S1473-3099(21)00612-5","article-title":"Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review","volume":"22","author":"Uyttebroek","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2024121909173284000_bib56","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/MPG.0000000000002655","article-title":"Probiotics and preterm infants: a position paper by the European Society for Paediatric Gastroenterology Hepatology and Nutrition Committee on Nutrition and the European Society for Paediatric Gastroenterology Hepatology and Nutrition Working Group for Probiotics and Prebiotics","volume":"70","author":"van\u00a0den\u00a0Akker","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024121909173284000_bib57","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.2020.1166","article-title":"Estimated research and development investment needed to bring a new medicine to market, 2009\u20132018","volume":"323","author":"Wouters","year":"2020","journal-title":"JAMA"},{"key":"2024121909173284000_bib58","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41586-023-06809-8","article-title":"Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization","volume":"624","author":"Ye","year":"2023","journal-title":"Nature"},{"key":"2024121909173284000_bib59","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2471\/BLT.22.288614","article-title":"The WHO AWaRe (Access, Watch, Reserve) antibiotic book and prevention of antimicrobial resistance","volume":"101","author":"Zanichelli","year":"2023","journal-title":"Bull World Health Org"},{"key":"2024121909173284000_bib60","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMc2202705","article-title":"A zoonotic henipavirus in febrile patients in China","volume":"387","author":"Zhang","year":"2022","journal-title":"N Engl J Med"}],"container-title":["Sustainable Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/sumbio\/advance-article-pdf\/doi\/10.1093\/sumbio\/qvae018\/58537104\/qvae018.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/sumbio\/article-pdf\/1\/1\/qvae018\/61195752\/qvae018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/sumbio\/article-pdf\/1\/1\/qvae018\/61195752\/qvae018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T09:18:22Z","timestamp":1734599902000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/sumbio\/article\/doi\/10.1093\/sumbio\/qvae018\/7713459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,17]]}},"URL":"https:\/\/doi.org\/10.1093\/sumbio\/qvae018","relation":{},"ISSN":["2755-1970"],"issn-type":[{"value":"2755-1970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1]]},"published":{"date-parts":[[2024,1]]},"article-number":"qvae018"}}